SIM-688

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSIM-688
Drug Alias NameSIM-688WAY-204688
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors agonistsNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complexEstrogen receptors
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer IncArqule Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArqule IncPfizer Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A